BACK TO CONTENTS   |    PDF   |    PREVIOUS   |    NEXT

Title

 

 

 

 

 

Comparative study of antioxidants as cancer preventives through inhibition of HIF-1 alpha activity

 

Authors

 

Jyoti Upadhyay, Rajesh K. Kesharwani, Krishna Misra*

 

Affiliation

 

Indian Institute of Information Technology, Allahabad, India-211002

 

Email

 

krishnamisra@hotmail.com

Article Type

 

Hypothesis

 

Date

 

Received May 15, 2009; Revised June 18, 2009; Accepted November 15, 2009; Published December 06, 2009

 

Abstract

HIF-1 α (hypoxia inducible factor-1 α isoform) has been exploited as a target in cancer therapeutics. HIF-1 α is the isoform-2 of HIF-1 α subunit. It is a 735 residues long protein modeled in this study. The HIF-1 α is absolutely critical for continued survival of cancer cells as it is involved in the activation of glycolysis and it helps an oxygen-starved cell convert sugar to energy without using oxygen. It also initiates angiogenesis to bring in a fresh oxygen supply. HIF-1 α operates only in presence of free radicals. In the present study, five antioxidants, namely lycopene, ascorbic acid, α-tocopherol, curcumin and curcumin dipiperoyl ester which are potent scavengers of reactive oxygen species (ROS) have been docked to HIF-1 α modeled protein in order to assess their binding and consequently, their inhibitory activity. The binding energy score has been found to be in the order, curumin dipiperoyl ester > lycopene > curcumin > tocopherol > ascorbic acid. However, subsequent experiments should be designed to validate these observations.

 

Citation

 

Received May 15, 2009; Revised June 18, 2009; Accepted November 15, 2009; Published December 06, 2009

Edited by

 

P. Kangueane

 

ISSN

 

0973-2063

 

Publisher

 

Biomedical Informatics

License

 

 

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.